Ibuprofen API Market Size & Share, by Application (Headache, Arthritis); End-User (CROs & CMOs, Pharmaceutical & Biopharmaceutical Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5471
  • Published Date: Dec 22, 2023
  • Report Format: PDF, PPT

Companies Dominating the Ibuprofen API Market

    • Azelis
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Lonza
    • BIOCAUSE Inc.
    • IOL Chemicals and Pharmaceuticals Limited
    • Granules India Limited
    • Sri Krishna Pharmaceuticals Ltd.
    • Taj Pharmaceuticals Limited
    • Anantco Enterprises Pvt. Ltd.
    • Wellona Pharma

Browse Key Market Insights with Data Illustration:


In The News

  • September 19, 2022: Azelis, a prominent worldwide innovation service provider in the food additives and specialty chemicals sector, is pleased to announce that it has entered into a new distribution deal with the esteemed specialty chemical manufacturer Clariant. Customers of Azelis in Austria, Germany, and Switzerland now have instant access to the whole line of active pharmaceutical ingredients (API) and excipients from Clariant.
  • March 8, 2022: At its active pharmaceutical ingredients (API) manufacturing facility in Nansha, China, Lonza, a global manufacturing partner to the biotech, nutrition, and pharmaceutical industries, today announced the completion of a laboratory expansion. With regard to the clinical supply of highly-potent APIs (HPAPI), the expansion primarily aimed to increase the capabilities and capacity of development laboratories and kilogram-scale cGMP manufacturing laboratories.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5471
  • Published Date: Dec 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are growth in number of women menstruating, rise in need for growth in drug development, and surge in prevalence of musculoskeletal disorders in pediatrics.

The market size of ibuprofen API is anticipated to attain a CAGR of 3% over the forecast period, i.e., 2024-2036.

The major players in the market are Azelis, Lonza, BIOCAUSE Inc., IOL Chemicals and Pharmaceuticals Limited and others.

The arthritis segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying